India · Delayed Price · Currency is INR Laurus Labs Company Description
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
The company offers Generics APIs and solid oral drug products for intermediates for anti-retroviral (ARV), anti-diabetic, cardiovascular, anti-asthma, ophthalmology, oncology, and gastroenterology.
It also provides biotechnology services that develops and manufactures animal-origin-free recombinant proteins and cell-culture media supplements and research and development services, including drug substance development, drug product development, and biologics development.
In addition, the company also offers non-human ingredients; rare disease therapeutics; and finished dosages.
Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
| Country | India |
| Founded | 2005 |
| Industry | Medicinal Chemicals and Botanical Products |
| Employees | 7,059 |
| CEO | Satyanarayana Chava |
Contact Details
Address: Jubilee Hills Hyderabad, Andhra Pradesh 500033 India | |
| Phone | 91 40 6659 4333 |
| Website | lauruslabs.com |
Stock Details
| Ticker Symbol | 540222 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Satyanarayana Chava | Chief Executive Officer |
| Vantaram Venkata Kumar | Chief Financial Officer |
| B. V. R. K. Suryadevara Rao | Chief Operating Officer |
| Vivek Kumar | Head of Investor Relations |